Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
Vous n'êtes pas connecté
In a new study, clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) have demonstrated the use of exosomes to successfully target squamous cell cancer tumours that are usually resistant to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). Their research is the first where exosomes have been applied to target TKI-resistant cancers in [...]
Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
Scientists say their Rutava technology able to target cancerous cells only, raising hopes for cure for all cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...
A World Health Organisation review of more than 5000 studies, led by Australian scientists, found no increased risk of several cancers associated with...
Exosomes, which are excreted by all live cells, contain cell components such as DNA, RNA, medlinklipids/medlink, and proteins. When they are...
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...
Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...